Thirty-two women ( 38.6 % ) reached CD4 counts of < 350 cells per microliter at median 9.4 months postinfection , 13 ( 40.6 % ) from the tenofovir and 19 ( 37.3 % ) from the placebo arms ( P = 0.786 ) .